Baizabal-Carvallo, José Fidel http://orcid.org/0000-0002-8614-5563
Jankovic, Joseph
Article History
Received: 29 June 2021
Accepted: 16 July 2021
First Online: 23 July 2021
Declarations
:
: None for all authors. Financial Disclosures for the previous 12 months: Royalties: Dr. Baizabal-Carvallo has received royalties from Medlink Neurology, Editorial Boards: Dr. Baizabal-Carvallo serves as Associated Editor in BMC Neurology. Dr. Jankovic: Research Support: Allergan, Inc; Allon Therapeutics; Biotie; Ceregene, Inc; Chelsea Therapeutics; Diana Helis Henry Medical Research Foundation; EMD Serono; Huntington’s Disease Society of America; Huntington Study Group; Impax Pharmaceuticals; Ipsen Limited; Lundbeck Inc; Medtronic; Merz Pharmaceuticals; Michael J Fox Foundation for Parkinson Research; National Institutes of Health; National Parkinson Foundation; Neurogen; St. Jude Medical; Teva Pharmaceutical Industries Ltd; University of Rochester; Parkinson Study Group. Consultant or Advisory Committee Member: Allergan, Inc; AstraZeneca, Chelsea Therapeutics; EMD Serono; Lundbeck Inc; Merz Pharmaceuticals; Michael J Fox Foundation for Parkinson Research; Neurocrine Biosciences, Inc; Teva Pharmaceutical Industries Ltd. Editorial Boards: Elsevier; Medlink: Neurology; Neurology in Clinical Practice; Neurotoxin Institute; Scientiae; UpToDate.
: We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. The authors confirm that the approval of an institutional review board was not required for this work; however, all patients provided signed written informed consent for video recording and its publication approved by the Baylor College of Medicine Review Board.